Modulation of chemokines by staphylococcal superantigen in atopic dermatitis

Chemical Immunology and Allergy

Volumn 93, Issue 1, 2007, Pages 181-194

  Homey, Bernard ^a   Meller, Stephan ^a   Savinko, Terhi ^b   Alenius, Harri ^b   Lauerma, Antti ^b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CX3C CHEMOKINE; EOTAXIN; IMMUNOGLOBULIN E; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 4; RANTES; STAPHYLOCOCCUS ENTEROTOXIN B; SUPERANTIGEN; THYMUS AND ACTIVATION REGULATED CHEMOKINE; CHEMOKINE RECEPTOR;

ARTICLE; ATOPIC DERMATITIS; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE SEVERITY; GENETIC PREDISPOSITION; HUMAN; MICROBIAL IMMUNITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PRURITUS; RELAPSE; SKIN INFLAMMATION; STAPHYLOCOCCUS; TH1 CELL; TH2 CELL; ANIMAL; BIOSYNTHESIS; IMMUNOLOGY; REVIEW;

ANIMALS; CHEMOKINES; DERMATITIS, ATOPIC; HUMANS; RECEPTORS, CHEMOKINE; STAPHYLOCOCCUS; SUPERANTIGENS; TH1 CELLS; TH2 CELLS;

EID: 34249671150     PISSN: 16602242     EISSN: None     Source Type: Book Series    
DOI: 10.1159/0000100895     Document Type: Article

References (78)

1. Leung DY, Bieber T: Atopic dermatitis. Lancet 2003;361:151-160.
2. Homey B, Steinhoff M, Ruzicka T, Leung DY: Cytokines and chemokines orchestrate atopic skin inflammation. J Allergy Clin Immunol 2006;118:178-189.
3. Stander S, Steinhoff M: Pathophysiology of pruritus in atopic dermatitis: An overview. Exp Dermatol 2002;11:12-24.
4. Campbell JJ, Butcher EC: Chemokines in tissue-specific and microenvironment-specific lymphocyte homing. Curr Opin Immunol 2000;12:336-341.
5. Homey B, Alenius H, Muller A, Soto H, Bowman EP, Yuan W, McEvoy L, Lauerma AI, Assmann T, Bunemann E, Lehto M, Wolff H, Yen D, Marxhausen H, To W, Sedgwick J, Ruzicka T, Lehmann P, Zlotnik A: CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nat Med 2002;8:157-165.
6. Reiss Y, Proudfoot AE, Power CA, Campbell JJ, Butcher EC: CC chemokine receptor (CCR)4 and the CCR10 ligand cutaneous T cell-attracting chemokine (CTACK) in lymphocyte trafficking to inflamed skin. J Exp Med 2001;194:1541-1547.
7. Soumelis V, Reche PA, Kanzler H, Yuan W, Edward G, Homey B, Gilliet M, Ho S, Antonenko S, Lauerma A, Smith K, Gorman D, Zurawski S, Abrams J, Menon S, McClanahan T, de Waal- Malefyt Rd R, Bazan F, Kastelein RA, Liu YJ: Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 2002;3:673-680.
8. Gilliet M, Soumelis V, Watanabe N, Hanabuchi S, Antonenko S, de Waal-Malefyt R, Liu YJ: Human dendritic cells activated by TSLP and CD40L induce proallergic cytotoxic T cells. J Exp Med 2003;197:1059-1063.
9. Li M, Messaddeq N, Teletin M, Pasquali JL, Metzger D, Chambon P: Retinoid X receptor ablation in adult mouse keratinocytes generates an atopic dermatitis triggered by thymic stromal lymphopoietin. Proc Natl Acad Sci USA 2005;102:14795-14800.
10. Yoo J, Omori M, Gyarmati D, Zhou B, Aye T, Brewer A, Comeau MR, Campbell DJ, Ziegler SF: Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin. J Exp Med 2005;202:541-549.
11. Liu YJ: Thymic stromal lMmphopoietin: master switch for allergic inflammation. J Exp Med 2006;203:269-273.
12. Nomura I, Gao B, Boguniewicz M, Darst MA, Travers JB, Leung DY: Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: A gene microarray analysis. J Allergy Clin Immunol 2003;112:1195-1202.
13. Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, Gallo RL, Leung DY: Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002;347:1151-1160.
14. Dillon SR, Sprecher C, Hammond A, Bilsborough J, Rosenfeld-Franklin M, Presnell SR, Haugen HS, Maurer M, Harder B, Johnston J, Bort S, Mudri S, Kuijper JL, Bukowski T, Shea P, Dong DL, Dasovich M, Grant FJ, Lockwood L, Levin SD, LeCiel C, Waggie K, Day H, Topouzis S, Kramer J, Kuestner R, Chen Z, Foster D, Parrish-Novak J, Gross JA: Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol 2004;5:752-760.
15. Schmelz M: Itch - Mediators and mechanisms. J Dermatol Sci 2002;28:91-96.
16. Steinhoff M, Neisius U, Ikoma A, Fartasch M, Heyer G, Skov PS, Luger TA, Schmelz M: Proteinase-activated receptor-A mediates itch: a novel pathway for pruritus in human skin. J Neurosci 2003;23:6176-6180.
17. Breuer K, Wittmann M, Bosche B, Kapp A, Werfel T: Severe atopic dermatitis is associated with sensitization to staphylococcal enterotoxin B (SEB). Allergy 2000;55:551-555.
18. Breuer K, Kapp A, Werfel T: Bacterial infections and atopic dermatitis. Allergy 2001;56: 1034-1041.
19. Novak N, Bieber T, Leung DY: Immune mechanisms leading to atopic dermatitis. J Allergy Clin Immunol 2003;112:S128-S139.
20. Kadowaki N, Ho S, Antonenko S, Malefyt RW, Kastelein RA, Bazan F, Liu YJ: Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med 2001;194:863-869.
21. Breuer K, Haussler S, Kapp A, Werfel T: Staphylococcus aureus: colonizing features and influence of an antibacterial treatment in adults with atopic dermatitis. Br J Dermatol 2002;147:55-61.
22. Homey B, Zlotnik A: Chemokines in allergy. Curr Opin Immunol 1999;11:626-634.
23. ZlotniA A, Yoshie O: Chemokines: a new classification system and their role in immunity. Immunity 2000;12:121-127.
24. Rossi D, Zlotnik A: The biology of chemokines and their receptors. Annu Rev Immunol 2000;18: 217-242.
25. Mohle R, Bautz F, Rafii S, Moore MA, Brugger W, Kanz L: The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1. Blood 1998;91:4523-4530.
26. Zou YR, Kottmann AH, Kuroda M, Taniuchi I, Littman DR: Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 1998;393:595-599.
27. Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verastegui E, Zlotnik A: Involvement of chemokine receptors in breast cancer metastasis. Nature 2001;410:50-56.
28. Balkwill F: Cancer and the chemokine network. Nat Rev Cancer 2004;4:540-550.
29. Homey A, Muller A, Zlotnik A: Chemokines: agents for the immunotherapy of cancer? Nat Rev Immunol 2002;2:175-184.
30. Forster R, Schubel A, Breitfeld D, Kremmer E, Renner-Muller I, Wolf E, Lipp M: CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 1999;99:23-33.
31. Ohl L, Henning G, Krautwald S, Lipp M, Hardtke S, Bernhardt G, Pabst O, Forster R: Cooperating mechanisms of CXCR5 and CCR7 in development and organization of secondary lymphoid organs. J Exp Med 2003;197:1199-1204.
32. Muller G, Hopken UE, Lipp M: The impact of CCR7 and CXCR5 on lymphoid organ development and systemic immunity. Immunol Rev 2003;195:117-135.
33. Caux C, Ait-Yahia S, Chemin K, de Bouteiller O, Dieu-Nosjean MC, Homey B, Massacrier C, Vanbervliet B, Zlotnik A, Vicari A: Dendritic cell biology and regulation of dendritic cell trafficking by chemokines. Springer Semin Immunopathol 2000;22:345-369.
34. Papadakis KA, Prehn J, Nelson V, Cheng L, Binder SW, Ponath PD, Andrew DP, Targan SR: The role of thymus-expressed chemokine and its receptor CCR9 on lymphocytes in the regional specialization of the mucosal immune system. J Immunol 2000;165:5069-5076.
35. Svensson M, Marsal J, Ericsson A, Carramolino L, Broden T, Marquez G, Agace WW: CCL25 mediates the localization of recently activated CD8alphabeta(+) lymphocytes to the small-intestinal mucosa. J Clin Invest 2002;110:1113-1121.
36. Butcher EC, Picker LJ: Lymphocyte homing and homeostasis. Science 1996,272:60-66.
37. Sallusto F, Palermo B, Hoy A, Lanzavecchia A: The role of chemokine receptors in directing traffic of naive, type 1 and type 2 T cells. Curr Top Microbiol Immunol 246:123-129.
38. Sallusto F, Lanzavecchia A: Mobilizing dendritic cells for tolerance, priming, and chronic inflammation. J Exp Med 1999;189:611-614.
39. Sallusto F, Lanzavecchia A, Mackay CR: Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol Today 1998;19:568-574.
40. Sallusto F, Lenig D, Mackay CR, Lanzavecchia A: Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 1998;187:875-883.
41. Bonecchi R, Bianchi G, Bordignon PP, D'Ambrosio D, Lang R, Borsatti A, Sozzani S, Allavena P, Gray PA, Mantovani A, Sinigaglia F: Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 1998;187:129-134.
42. Zingoni A, Soto H, Hedrick JA, Stoppacciaro A, Storlazzi CT, Sinigaglia F, D'Ambrosio D, O'Garra A, Robinson D, Rocchi M, Santoni A, Zlotnik A, Napolitano M: The chemokine receptor CCR8 is preferentially expressed in Th2 but not Th1 cells. J Immunol 1998;161:547-551.
43. Kim CH, Rott L, Kunkel EJ, Genovese MC, Andrew DP, Wu L, Butcher EC: Rules of chemokine receptor association with T cell polarization in vivo. J Clin Invest 2001;108:1331-1339.
44. Gombert M, Dieu-Nosjean MC, Winterberg F, Bünemann E, Kubitza RC, Da Cunha L, Haahtela A, Lehtimäki S, Rieker J, Meller S, Pivarcsi A, Koreck A, Fridman WH, Zentgraf HW, Pavenstädt H, Amara A, Caux C, Kemeny L, Alenius H, Lauerma A, Ruzicka T, Zlotnik A, Homey B: CCL1- CCR8 interactions: An axis mediating the recruitment of T cells and Langerhans-type dendritic cells to sites of atopic skin inflammation. J Immunol 2005;174:5082-5091.
45. Kaburagi Y, Shimada Y, Nagaoka T, Hasegawa M, Takehara K, Sato S: Enhanced production of CC-chemokines (RANTES, MCP-1, MIP-1alpha, MIP-1beta, and eotaxin) in patients with atopic dermatitis. Arch Dermatol Res 2001;293:350-355.
46. Gluck J, Rogala B: Chemokine RANTES in atopic dermatitis. Arch Immunol Ther Exp (Warsz) 1999;47:367-372.
47. Niwa Y: Elevated RANTES levels in plasma or skin and decreased plasma IL-10 levels in subsets of patients with severe atopic dermatitis. Arch Dermatol 2000;136:125-126.
48. Park CW, Lee BH, Han HJ, Lee CH, Ahn HK: Tacrolimus decreases the expression of eotaxin, CCR3, RANTES and interleukin-5 in atopic dermatitis. Br J Dermatol 2005;152:1173-1181.
49. Yamada H, Chihara J, Matsukura M, Yasuba H, Yudate T, Tezuka T: Elevated plasma RANTES levels in patients with atopic dermatitis. J Clin Lab Immunol 1996;48:87-91.
50. Yawalkar N, Uguccioni M, Scharer J, Braunwalder J, Karlen S, Dewald B, Braathen LR, Baggiolini M: Enhanced expression of eotaxin and CCR3 in atopic dermatitis. J Invest Dermatol 1999;113:43-48.
51. Leung TF, Wong CK, Chan IH, Ip WK, Lam CW, Wong GW: Plasma concentration of thymus and activation-regulated chemokine is elevated in childhood asthma. J Allergy Clin Immunol 2002;110: 404-409.
52. Jahnz-Rozyk K, Targowski T, Paluchowska E, Owczarek W, Kucharczyk A: Serum thymus and activation-regulated chemokine, macrophage-derived chemokine and eotaxin as markers of severity of atopic dermatitis. Allergy 2005;60:685-688.
53. Hossny E, Aboul-Magd M, Bakr S: Increased plasma eotaxin in atopic dermatitis and acute urticaria in infants and children. Allergy 2001;56:996-1002.
54. Taha RA, Minshall EM, Leung DY, Boguniewicz M, Luster A, Muro S, Toda M, Hamid QA: Evidence for increased expression of eotaxin and monocyte chemotactic protein-4 in atopic dermatitis. J Allergy Clin Immunol 2000;105:1002-1007.
55. Hijnen D, De Bruin-Weller M, Oosting B, Lebre C, De Jong E, Bruijnzeel-Koomen C, Knol E: Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell-attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis. J Allergy Clin Immunol 2004;113:334-340.
56. Kakinuma T, Nakamura K, Wakugawa M, Mitsui H, Tada Y, Saeki H, Torii H, Asahina A, Onai N, Matsushima K, Tamaki K: Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity. J Allergy Clin Immunol 2001;107:535-541.
57. Lin L, Nonoyama S, Oshiba A, Kabasawa Y, Mizutani S: TARC and MDC are produced by CD40 activated human B cells and are elevated in the sera of infantile atopic dermatitis patients. J Med Dent Sci 2003;50:27-33.
58. Morita E, Hiragun T, Mihara S, Kaneko S, Matsuo H, Zhang Y, Dekio S: Determination of thymus and activation-regulated chemokine (TARC)-contents in scales of atopic dermatitis. J Dermatol Sci 2004;34:237-240.
59. Uchida T, Suto H, Ra C, Ogawa H, Kobata T, Okumura K: Preferential expression of T(h)2-type chemokine and its receptor in atopic dermatitis. Int Immunol 2002;14:1431-1438.
60. Pivarcsi A, Gombert M, Dieu-Nosjean MC, Lauerma A, Kubitza R, Meller S, Rieker J, Muller A, Da Cunha L, Haahtela A, Sonkoly E, Fridman WH, Alenius H, Kemeny L, Ruzicka T, Zlotnik A, Homey B: CC chemokine ligand 18, an atopic dermatitis-associated and dendritic cell-derived chemokine, is regulated by staphylococcal products and allergen exposure. J Immunol 2004;173: 5810-5817.
61. Gunther C, Bello-Fernandez C, Kopp T, Kund J, Carballido-Perrig N, Hinteregger S, Fassl S, Schwarzler C, Lametschwandtner G, Stingl G, Biedermann T, Carballido JM: CCL18 is expressed in atopic dermatitis and mediates skin homing of human memory T cells. J Immunol 2005;174: 1723-1728.
62. Nakayama T, Fujisawa R, Yamada H, Horikawa T, Kawasaki H, Hieshima K, Izawa D, Fujiie S, Tezuka T, Yoshie O: Inducible expression of a CC chemokine liver- and activation-regulated chemokine (LARC)/macrophage inflammatory protein (MIP)-3 alpha/CCL20 by epidermal keratinocytes and its role in atopic dermatitis. Int Immunol 2001;13:95-103.
63. Horikawa T, Nakayama T, Hikita I, Yamada H, Fujisawa R, Bito T, Harada S, Fukunaga A, Chantry D, Gray PW, Morita A, Suzuki R, Tezuka T, Ichihashi M, Yoshie O: IFN-gamma-inducible expression of thymus and activation-regulated chemokine/CCL17 and macrophage-derived chemokine/ CCL22 in epidermal keratinocytes and their roles in atopic dermatitis. Int Immunol 2002;14:767-773.
64. Leung TF, Ma KC, Hon KL, Lam CW, Wan H, Li CY, Chan IH: Serum concentration of macrophage-derived chemokine may be a useful inflammatory marker for assessing severity of atopic dermatitis in infants and young children. Pediatr Allergy Immunol 2003;14:296-301.
65. Kagami S, Kakinuma T, Saeki H, Tsunemi Y, Fujita H, Nakamura K, Takekoshi T, Kishimoto M, Mitsui H, Torii H, Komine M, Asahina A, Tamaki K: Significant elevation of serum levels of eotaxin-3/CCL26, but not of eotaxin-2/CCL24, in patients with atopic dermatitis: Serum eotaxin-3/ CCL26 levels reflect the disease activity of atopic dermatitis. Clin Exp Immunol 2003;134:309-313.
66. Shimada Y, Takehara K, Sato S: Both Th2 and Th1 chemokines (TARC/CCL17, MDC/CCL22, and Mig/CXCL9) are elevated in sera from patients with atopic dermatitis. J Dermatol Sci 2004;34:201-208.
67. Hon KL, Leung TF, Ma KC, Li AM, Wong Y, Fok TF: Serum levels of cutaneous T-cell attracting chemokine (CTACK) as a laboratory marker of the severity of atopic dermatitis in children. Clin Exp Dermatol 2004;29:293-296.
68. Kakinuma T, Nakamura K, Wakugawa M, Mitsui H, Tada Y, Saeki H, Torii H, Komine M, Asahina A, Tamaki K: Serum macrophage-derived chemokine (MDC) levels are closely related with the disease activity of atopic dermatitis. Clin Exp Immunol 2002;127:270-273.
69. Kakinuma T, Saeki H, Tsunemi Y, Fujita H, Asano N, Mitsui H, Tada Y, Wakugawa M, Watanabe T, Torii H, Komine M, Asahina A, Nakamura K, Tamaki K: Increased serum cutaneous T cellattracting chemokine (CCL27) levels in patients with atopic dermatitis and psoriasis vulgaris. J Allergy Clin Immunol 2003;111:592-597.
70. Echigo T, Hasegawa M, Shimada Y, Takehara K, Sato S: Expression of fractalkine and its receptor, CX3CR1, in atopic dermatitis: Possible contribution to skin inflammation. J Allergy Clin Immunol 2004,113:940-948.
71. Harder J, Bartels J, Christophers E, Schroder JM: A peptide antibiotic from human skin. Nature 1997;387:861.
72. Harder J, Bartels J, Christophers E, Schroder JM: Isolation and characterization of human betadefensin-3, a novel human inducible peptide antibiotic. J Biol Chem 2001;276:5707-5713.
73. Schibli DJ, Hunter HN, Aseyev V, Starner TD, Wiencek JM, McCray PB Jr, Tack BF, Vogel HJ: The solution structures of the human beta-defensins lead to a better understanding of the potent bactericidal activity of HBD3 against Staphylococcus aureus. J Biol Chem 2002;277:8279-8289.
74. Nomura I, Goleva E, Howell MD, Hamid QA, Ong PY, Hall CF, Darst MA, Gao B, Boguniewicz M, Travers JB, Leung DY: Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol 2003;171:3262-3269.
75. Laouini D, Kawamoto S, Yalcindag A, Bryce P, Mizoguchi E, Oettgen H, Geha RS: Epicutaneous sensitization with superantigen induces allergic skin inflammation. J Allergy Clin Immunol 2003;112:981-987.
76. Savinko T, Lauerma A, Lehtimaki S, Gombert M, Majuri ML, Fyhrquist-Vanni N, Dieu-Nosjean MC, Kemeny L, Wolff H, Homey B, Alenius H: Topical superantigen exposure induces epidermal accumulation of CD8+ T cells, a mixed Th1/Th2-type dermatitis and vigorous production of IgE antibodies in the murine model of atopic dermatitis. J Immunol 2005;175:8320-8326.
77. Bilsborough J, Leung DY, Maurer M, Howell M, Boguniewcz M, Yao L, Storey H, Leciel C, Harder B, Gross JA: IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis. J Allergy Clin Immunol 2006;117:418-425.
78. Sonkoly E, Muller A, Lauerma AI, Pivarcsi A, Soto H, Kemeny L, Alenius H, Dieu-Nosjean MC, Meller S, Rieker J, Steinhoff M, Hoffmann TK, RAzicka T, Zlotnik A, Homey B: IL-31: a new link between T cells and pruritus in atopic skin inflammation. J Allergy Clin Immunol 2006;117:411-417.